medigraphic.com

2011, Número 2

Siguiente >>

Rev Cuba Endoc 2011; 22 (2)


Sobre el uso clínico de la determinación de la insulina

González SRM

Idioma: Español
Referencias bibliográficas: 23
Paginas: 64-68
Archivo PDF: 32.73 Kb.


FRAGMENTO

En este número de la Revista Cubana de Endocrinología, así como en muchos de los anteriores, aparecen trabajos dedicados al tema de la metodología analítica para el estudio de la sensibilidad a la insulina. Este tema, por su actualidad e importancia, merece una especial atención y unos comentarios que sirvan para estimular a nuestros colegas a estudiarlo e incorporarse a su investigación.


REFERENCIAS (EN ESTE ARTÍCULO)

  1. Himsworth HP. Diabetes mellitus: its differentiation into insulin-sensitive and insulin-insensitive types. Lancet. 1936;227:127-30.

  2. Reaven G. Role of insulin resistance in human disease. Diabetes. 1988;37:1595- 607.

  3. Ranganath Muniyappa, Sihoon Lee, Hui Chen, Michael J Quon. Current approaches for assessing insulin sensitivity and resistance in vivo: advantages, limitations, and appropriate usage. Am J Physiol Endocrinol Metab. 2008;294:E15-E26.

  4. Mehta NN, Krishnamoorthy P, Martin SS, St Clair C, Schwartz S, Iqbal N, et al. Usefulness of insulin resistance estimation and the metabolic syndrome in predicting coronary atherosclerosis in type 2 diabetes mellitus. Am J Cardiol. 2011;107:406-11.

  5. The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus: follow-up report on the diagnosis of diabetes mellitus. Diabetes Care. 2003;26:3160- 7.

  6. Boronat M, Saavedra P, Varillas VF, Wagner AM, López-Plasencia Y, Alberiche MP, et al. Differences in traditional and emerging cardiovascular risk factors of subjects discordantly classified by metabolic syndrome definitions of the International Diabetes Federation and the National Cholesterol Education Program. Nutr Metab CardiovascDis. 2009;19:417-22.

  7. González Suárez RM, Perich Amador P, Arranz Calzado C. Trastornos metabólicos asociados con la evolución hacia la diabetes mellitus tipo 2 en una población en riesgo. Rev Cubana Endocrinol. 2010;21:110-25.

  8. González Suárez RM. Un nuevo paradigma para la época de la prevención de la diabetes. Rev Cubana Endocrinol. 2009;20:40-50.

  9. DeFronzo RA. Insulin resistance, lipotoxicity, type 2 diabetes and atherosclerosis: the missing links. The Claude Bernard Lecture 2009. Diabetologia. 2010;53:1270-87.

  10. Isomaa B, Almgren P, Tuomi T. Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care. 2001;24:683-9.

  11. Bonora E, Formentini G, Calcaterra F. HOMA estimated insulin resistance is an independent predictor of cardiovascular disease in type 2 diabetic subjects: prospective data from the Verona Diabetes Complications Study. Diabetes Care. 2002;25:1135-41.

  12. Howard G, O'Leary DH, Zaccaro D, Haffner S, Rewers M, Hamman R, et al. Insulin sensitivity and atherosclerosis. The Insulin Resistance Atherosclerosis Study (IRAS) Investigators. Circulation. 1996;93:1809-17.

  13. Gerstein HC, Miller ME, Byington RP, Goff DC Jr., Bigger JT, Buse JB, et al. Effects of intensive glucose lowering in type 2 diabetes. N Engl J Med. 2008;358:2345-59.

  14. Patel A, MacMahon S, Chalmers J, Neal B, Billot L, Woodward M, et al. Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. New Engl J Med. 2008;358:2560-725.

  15. Duckworth W, Abraira C, Mortiz T, Reda D, Emanuele N, Reaven PD, et al. Glucose control and vascular complications in veterans with type 2 diabetes. N Engl J Med. 2009;360:129-39.

  16. D'Agostino RB Sr, Grundy S, Sullivan LM, Wilson P, CHD Risk Prediction Group. Validation of the Framingham coronary heart disease prediction scores: results of a multiple ethnic groups investigation. JAMA. 2001;286:180-7.

  17. Wilson PWF, D'Agostino RB, Levy D, Belanger AM, Silbershatz H, Kannel WB. Prediction of coronary heart disease using risk factors categories. Circ. 1998;97:1837- 47.

  18. Kon Koh, MJ Quon. Dysfunction: molecular and pathophysiological mechanisms reciprocal relationships between insulin resistance and endothelial disfunction. Circulation. 2006;113:1888-904.

  19. Zhou MS. Vascular insulin resistance: a potential link between cardiovascular and metabolic diseases. Current Hypertension Reports. 2009;11:48-55.

  20. Allende-Vigo MZ. Pathophysiologic mechanisms linking adipose tissue and cardiometabolic risk. Endocr Pract. 2010;16:692-8.

  21. Hoofnagle AN, Vaisar T, Mitra P, Chait A. HDL lipids and insulin resistance. Curr Diab Rep. 2010;10:78-86.

  22. Olefsky JM, Glass CK. Macrophages, inflammation, and insulin resistance. Annu Rev Physiol. 2010;72:219-46.

  23. Reaven G. Wanted!: a standardized measurement of plasma insulin concentration. Arterioscler Thromb Vasc Biol. 2011;31:954-5.




2020     |     www.medigraphic.com